0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight remicade drug insights2014.Your search for "" gave back 954510 results.
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
A Remicade biosimilar is a biologic medication that is highly similar to Remicade, a brand-name biologic used to treat autoimmune diseases such as...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Remicade (Infliximab) and Biosimilar market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
A biosimilar of Remicade is a biologic medication that is highly similar to the reference product, Remicade, in terms of safety, efficacy, and...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Remicade (Infliximab) Monoclonal Antibody market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029;...
Catalog:
LPI
June 2023
Price: USD 3,660.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
TNF inhibitors are drugs that help stop inflammation. They're used to treat diseases like rheumatoid arthritis (RA), juvenile arthritis,...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Biosimilar of Remicade market size was valued at US$ 292500 million in 2023. With growing demand in downstream market, the Biosimilar of...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Remicade Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Remicade Biosimilar is...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Remicade (Infliximab) and Biosimilar market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Remicade (Infliximab) Monoclonal Antibody market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Remicade (Infliximab) and Biosimilar market size was valued at USD 2623.8 million in 2022 and is forecast to a readjusted size of USD 3781...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global Biologic Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of %...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Remicade (Infliximab) Monoclonal Antibody market size was valued at USD 2623.8 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. According to our Publisher latest study, the global...
Catalog:
GIR
February 2023
Price: USD 3,480.00
